TEM Stereometric Analyses of Glomeruli in Aging OVE26 Transgenic Diabetic Mice

Background/Aims: Glomerular lesions in diabetic nephropathy (DN) have been studied in numerous murine diabetic models, but the critical feature of aging is often absent. Since histopathology indicates that in mice, DN glomerular lesions may just begin to develop at about 5 months of age, we utilized the long-lived OVE26 transgenic diabetic model for stereometric analyses of DN glomerulopathic aging. Methods: Albuminuria was determined by ELISA, and transmission electron microscopy stereometry was utilized exclusively to demonstrate changes in glomerular cell density and number, and alterations in the glomerular filtration barrier in OVE26 mice at 60, 150, and 450 days of age. Results: Compared to age-matched controls, albuminuria in diabetic mice is significant at 60 days. At 150 days, glomerular volume and mesangial, endothelial and total cell numbers, and podocyte effacement are significantly increased, while podocyte, endothelial, and total cell density are significantly decreased. Endothelial fenestrations are decreased, and glomerular basement membrane thickness is increased. At 450 days, stereometric alterations are exacerbated. Conclusion: Our data indicate that in OVE26 mice, albuminuria precedes morphological glomerular lesions and could be due to early-onset hyperglycemia. Moreover, in this model, most DN glomerulopathic lesions occur relatively late in life, and it is possible that they may result from prolonged hyperglycemia-induced oxidative stress.

[1]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[2]  Jianxiang Xu,et al.  FVB mouse genotype confers susceptibility to OVE26 diabetic albuminuria. , 2010, American journal of physiology. Renal physiology.

[3]  P. Epstein,et al.  Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[4]  P. Epstein,et al.  Podocyte Loss in Aging OVE26 Diabetic Mice , 2008, Anatomical record.

[5]  M. Caramori,et al.  Podocyte Detachment and Reduced Glomerular Capillary Endothelial Fenestration in Human Type 1 Diabetic Nephropathy , 2007, Diabetes.

[6]  S. Shankland,et al.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis. , 2006, Kidney international.

[7]  M. Schiffer,et al.  Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. , 2006, Diabetes.

[8]  S. Marshall The Podocyte: A Major Player in the Development of Diabetic Nephropathy? , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[9]  N. Metreveli,et al.  Development of late-stage diabetic nephropathy in OVE26 diabetic mice. , 2004, Diabetes.

[10]  Jessica A Risan,et al.  Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[11]  L. Klevay,et al.  Ultrastructural and functional analyses of nephropathy in calmodulin‐induced diabetic transgenic mice , 1997, The Anatomical record.

[12]  B. Chavers,et al.  Mesangial Expansion as a Central Mechanism for Loss of Kidney Function in Diabetic Patients , 1989, Diabetes.

[13]  S. Teutsch,et al.  The problem of diabetic renal failure in the United States: an overview. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  B. Chavers,et al.  Observations of glomerular epithelial cell structure in patients with type I diabetes mellitus. , 1987, Kidney international.

[15]  P S Baur,et al.  The use of PIPES buffer in the fixation of mammalian and marine tissues for electron microscopy , 1977, Journal of microscopy.

[16]  M. Karnovsky,et al.  A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron-microscopy , 1965 .